PROCEPT BioRobotics (NASDAQ:PRCT) vs. Spectral Medical (OTCMKTS:EDTXF) Financial Contrast

PROCEPT BioRobotics (NASDAQ:PRCTGet Free Report) and Spectral Medical (OTCMKTS:EDTXFGet Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, analyst recommendations, earnings, dividends and profitability.

Volatility & Risk

PROCEPT BioRobotics has a beta of 0.95, indicating that its stock price is 5% less volatile than the S&P 500. Comparatively, Spectral Medical has a beta of 0.82, indicating that its stock price is 18% less volatile than the S&P 500.

Analyst Ratings

This is a summary of current recommendations and price targets for PROCEPT BioRobotics and Spectral Medical, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PROCEPT BioRobotics 0 0 7 0 3.00
Spectral Medical 0 0 0 0 N/A

PROCEPT BioRobotics presently has a consensus target price of $61.20, suggesting a potential downside of 8.74%. Given PROCEPT BioRobotics’ higher probable upside, equities analysts plainly believe PROCEPT BioRobotics is more favorable than Spectral Medical.

Valuation and Earnings

This table compares PROCEPT BioRobotics and Spectral Medical’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
PROCEPT BioRobotics $136.19 million 25.32 -$105.90 million ($2.12) -31.63
Spectral Medical $1.18 million 85.05 -$11.60 million ($0.05) -7.20

Spectral Medical has lower revenue, but higher earnings than PROCEPT BioRobotics. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than Spectral Medical, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

89.5% of PROCEPT BioRobotics shares are owned by institutional investors. 17.4% of PROCEPT BioRobotics shares are owned by company insiders. Comparatively, 1.5% of Spectral Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.


This table compares PROCEPT BioRobotics and Spectral Medical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
PROCEPT BioRobotics -66.12% -41.35% -27.92%
Spectral Medical -1,033.07% N/A -263.26%


PROCEPT BioRobotics beats Spectral Medical on 8 of the 13 factors compared between the two stocks.

About PROCEPT BioRobotics

(Get Free Report)

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

About Spectral Medical

(Get Free Report)

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.

Receive News & Ratings for PROCEPT BioRobotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PROCEPT BioRobotics and related companies with's FREE daily email newsletter.